An Open-Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis - EASY: Extended Access to Sollpura over Years An Open-Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Exocrine Panc ...
Product Name: Liprotamasa INN or Proposed INN: SIN ASIGNAR Other descriptive name: LIPASA INN or Proposed INN: SIN ASIGNAR Other descriptive name: PROTEASA INN or Proposed INN: SIN ASIGNAR Other descriptive name: AMILASAProduct Name: Liprotamasa INN or Proposed INN: SIN ASIGNAR Other descriptive name: LIPASA INN or Propos ...
ANTHERA Pharmaceuticals, Inc.
NULL
Not Recruiting
Female: yes Male: yes
70
Phase 3
United States;Czech Republic;Hungary;Canada;Poland;Spain;Israel